ニュース
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes ...
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Some weight-loss drugs are being sold directly to consumers, bypassing insurance. Catholic devotees were stunned when an ...
(Yicai) June 27 -- China's drug regulator is expected to approve the country's first domestically produced glucagon-like ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
(Yicai) June 23 -- The efficacy of a glucagon-like peptide-1 weight-loss agonist developed by Chinese pharmaceutical firm ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する